{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:08:59Z","timestamp":1790507339624,"version":"4.1.0"},"reference-count":206,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.trsl.2016.11.005","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T07:02:52Z","timestamp":1479538972000},"page":"27-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Osteogenesis imperfecta: new genes reveal novel mechanisms in bone dysplasia"],"prefix":"10.1016","volume":"181","author":[{"given":"Heeseog","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Aryal A.C.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan C.","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2016.11.005_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrendo.2011.81","article-title":"New perspectives on osteogenesis imperfecta","volume":"7","author":"Forlino","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.trsl.2016.11.005_bib2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MOP.0000000000000117","article-title":"Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation","volume":"26","author":"Marini","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.trsl.2016.11.005_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0076-6879(87)45012-X","article-title":"Analysis of cytoplasmic and nuclear messenger RNA in fibroblasts from patients with type I osteogenesis imperfecta","volume":"145","author":"Genovese","year":"1987","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.trsl.2016.11.005_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/301689","volume":"62","author":"Korkko","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1172\/JCI118495","article-title":"Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta","volume":"97","author":"Redford-Badwal","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2016.11.005_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0945-053X(99)00056-6","article-title":"Nonsense mutations in the COL1A1 gene preferentially reduce nuclear levels of mRNA but not hnRNA in osteogenesis imperfecta type I cell strains. Matrix biology","volume":"19","author":"Slayton","year":"2000","journal-title":"J Int Soc Matrix Biol"},{"key":"10.1016\/j.trsl.2016.11.005_bib7","first-page":"799","article-title":"Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains","volume":"59","author":"Willing","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1651-2227.1991.tb12045.x","article-title":"Mutations in collagen genes as a cause of rare and perhaps common diseases of connective tissue","volume":"379","author":"Prockop","year":"1991","journal-title":"Acta Paediatr Scand Suppl"},{"key":"10.1016\/j.trsl.2016.11.005_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1056\/NEJM198408093110606","article-title":"Heritable diseases of collagen","volume":"311","author":"Prockop","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.11.005_bib10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1073\/pnas.89.3.957","article-title":"Analysis of CpG suppression in methylated and nonmethylated species","volume":"89","author":"Schorderet","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.11.005_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.20429","article-title":"Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans","volume":"28","author":"Marini","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2016.11.005_bib12","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1359\/jbmr.080804","article-title":"Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors","volume":"23","author":"Uveges","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib13","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2353\/ajpath.2010.090704","article-title":"Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine","volume":"176","author":"Li","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2016.11.005_bib14","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1089\/ten.tea.2009.0011","article-title":"The role of collagen crosslinking in differentiation of human mesenchymal stem cells and MC3T3-E1 cells","volume":"15","author":"Fernandes","year":"2009","journal-title":"Tissue Eng A"},{"key":"10.1016\/j.trsl.2016.11.005_bib15","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1359\/jbmr.2000.15.7.1330","article-title":"Pyridinium cross-links in bone of patients with osteogenesis imperfecta: evidence of a normal intrafibrillar collagen packing","volume":"15","author":"Bank","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib16","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1093\/hmg\/ddv328","article-title":"Altered cytoskeletal organization characterized lethal but not surviving Brtl+\/\u2212 mice: insight on phenotypic variability in osteogenesis imperfecta","volume":"24","author":"Bianchi","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1359\/jbmr.090720","article-title":"Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model","volume":"25","author":"Daley","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib18","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1371\/journal.pgen.0040007","article-title":"ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta","volume":"4","author":"Lisse","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1750-1172-8-78","article-title":"Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an osteogenesis imperfecta\/Ehlers-Danlos Syndrome overlap syndrome","volume":"8","author":"Malfait","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.trsl.2016.11.005_bib20","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1074\/jbc.M801982200","article-title":"Defective C-propeptides of the proalpha2(I) chain of type I procollagen impede molecular assembly and result in osteogenesis imperfecta","volume":"283","author":"Pace","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib21","first-page":"1330","article-title":"Type I procollagen C-propeptide defects: study of genotype-phenotype correlation and predictive role of crystal structure","volume":"35","author":"Symoens","year":"2014","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2016.11.005_bib22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/humu.21475","article-title":"COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta","volume":"32","author":"Lindahl","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2016.11.005_bib23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajhg.2012.02.026","article-title":"Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish","volume":"90","author":"Asharani","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/humu.21647","article-title":"Identification of a mutation causing deficient BMP1\/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta","volume":"33","author":"Martinez-Glez","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2016.11.005_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/humu.9430","article-title":"Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV","volume":"27","author":"Pollitt","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2016.11.005_bib26","doi-asserted-by":"crossref","first-page":"19259","DOI":"10.1074\/jbc.M414698200","article-title":"Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta\/Ehlers-Danlos syndrome by interference with N-propeptide processing","volume":"280","author":"Cabral","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib27","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.4161\/cc.6.14.4474","article-title":"Components of the collagen prolyl 3-hydroxylation complex are crucial for normal bone development","volume":"6","author":"Marini","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trsl.2016.11.005_bib28","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1056\/NEJMoa063804","article-title":"Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta","volume":"355","author":"Barnes","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.11.005_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","article-title":"CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta","volume":"127","author":"Morello","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2016.11.005_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng1968","article-title":"Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta","volume":"39","author":"Cabral","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/hmg\/ddn374","article-title":"Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships","volume":"18","author":"Bodian","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib32","doi-asserted-by":"crossref","first-page":"17641","DOI":"10.1074\/jbc.M109.007070","article-title":"Biochemical characterization of the prolyl 3-hydroxylase 1.cartilage-associated protein.cyclophilin B complex","volume":"284","author":"Ishikawa","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00441-009-0872-0","article-title":"Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta","volume":"339","author":"Marini","year":"2010","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib34","doi-asserted-by":"crossref","first-page":"e1004121","DOI":"10.1371\/journal.pgen.1004121","article-title":"Differential effects of collagen prolyl 3-hydroxylation on skeletal tissues","volume":"10","author":"Homan","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib35","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1021\/bi2019139","article-title":"Peptidyl 3-hydroxyproline binding properties of type I collagen suggest a function in fibril supramolecular assembly","volume":"51","author":"Hudson","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.trsl.2016.11.005_bib36","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1242\/jcs.110.12.1351","article-title":"Cartilage associated protein (CASP) is a novel developmentally regulated chick embryo protein","volume":"110","author":"Castagnola","year":"1997","journal-title":"J Cell Sci"},{"key":"10.1016\/j.trsl.2016.11.005_bib37","doi-asserted-by":"crossref","first-page":"23615","DOI":"10.1074\/jbc.M312807200","article-title":"Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes","volume":"279","author":"Vranka","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S8756-3282(02)00790-1","article-title":"Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease","volume":"31","author":"Ward","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.trsl.2016.11.005_bib39","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bone.2009.10.037","article-title":"CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII","volume":"46","author":"Fratzl-Zelman","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.trsl.2016.11.005_bib40","doi-asserted-by":"crossref","first-page":"e10560","DOI":"10.1371\/journal.pone.0010560","article-title":"Generalized connective tissue disease in Crtap\u2212\/\u2212 mouse","volume":"5","author":"Baldridge","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.trsl.2016.11.005_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddp481","article-title":"Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex","volume":"19","author":"Chang","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib42","doi-asserted-by":"crossref","first-page":"25004","DOI":"10.1074\/jbc.274.35.25004","article-title":"Molecular characterization of a novel basement membrane-associated proteoglycan, leprecan","volume":"274","author":"Wassenhove-McCarthy","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib43","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2350\/10-03-0806-CR.1","article-title":"Lethal\/severe osteogenesis imperfecta in a large family: a novel homozygous LEPRE1 mutation and bone histological findings","volume":"14","author":"van Dijk","year":"2011","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.trsl.2016.11.005_bib44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/gim.2011.44","article-title":"A founder mutation in LEPRE1 carried by 1.5% of West Africans and 0.4% of African Americans causes lethal recessive osteogenesis imperfecta","volume":"14","author":"Cabral","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.trsl.2016.11.005_bib45","doi-asserted-by":"crossref","first-page":"e36809","DOI":"10.1371\/journal.pone.0036809","article-title":"A novel mutation in LEPRE1 that eliminates only the KDEL ER- retrieval sequence causes non-lethal osteogenesis imperfecta","volume":"7","author":"Takagi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.11.005_bib46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/mgg3.21","article-title":"Allelic background of LEPRE1 mutations that cause recessive forms of osteogenesis imperfecta in different populations","volume":"1","author":"Pepin","year":"2013","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.trsl.2016.11.005_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/15513815.2012.754528","article-title":"Osteogenesis imperfecta due to compound heterozygosity for the LEPRE1 gene","volume":"32","author":"Moul","year":"2013","journal-title":"Fetal Pediatr Pathol"},{"key":"10.1016\/j.trsl.2016.11.005_bib48","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/BF02265286","article-title":"The molecular defect in a family with mild atypical osteogenesis imperfecta and extreme joint hypermobility: exon skipping caused by an 11-bp deletion from an intron in one COL1A2 allele","volume":"88","author":"Nicholls","year":"1992","journal-title":"Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib49","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/humu.20799","article-title":"CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta","volume":"29","author":"Baldridge","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2016.11.005_bib50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/jmg.2008.062729","article-title":"Recessive osteogenesis imperfecta caused by LEPRE1 mutations: clinical documentation and identification of the splice form responsible for prolyl 3-hydroxylation","volume":"46","author":"Willaert","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib51","doi-asserted-by":"crossref","first-page":"17253","DOI":"10.1074\/jbc.M110.102228","article-title":"Prolyl 3-hydroxylase 1 null mice display abnormalities in fibrillar collagen-rich tissues such as tendons, skin, and bones","volume":"285","author":"Vranka","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.matbio.2012.11.006","article-title":"Prolyl 3-hydroxylase-1 null mice exhibit hearing impairment and abnormal morphology of the middle ear bone joints","volume":"32","author":"Pokidysheva","year":"2013","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"key":"10.1016\/j.trsl.2016.11.005_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bone.2016.01.018","article-title":"Bone matrix hypermineralization in prolyl-3 hydroxylase 1 deficient mice","volume":"85","author":"Fratzl-Zelman","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.trsl.2016.11.005_bib54","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1074\/mcp.M111.016550","article-title":"An interaction map of endoplasmic reticulum chaperones and foldases","volume":"11","author":"Jansen","year":"2012","journal-title":"Mol Cell Proteomics MCP"},{"key":"10.1016\/j.trsl.2016.11.005_bib55","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1210\/jc.2016-1334","article-title":"Non-lethal type VIII osteogenesis imperfecta has elevated bone matrix mineralization","volume":"101","author":"Fratzl-Zelman","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2016.11.005_bib56","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJMoa0907705","article-title":"Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding","volume":"362","author":"Barnes","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.11.005_bib57","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ajhg.2009.09.001","article-title":"PPIB mutations cause severe osteogenesis imperfecta","volume":"85","author":"van Dijk","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib58","doi-asserted-by":"crossref","first-page":"22253","DOI":"10.1074\/jbc.M111.333336","article-title":"Mutation in cyclophilin B that causes hyperelastosis cutis in American Quarter Horse does not affect peptidylprolyl cis-trans isomerase activity but shows altered cyclophilin B-protein interactions and affects collagen folding","volume":"287","author":"Ishikawa","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib59","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/hmg\/ddr037","article-title":"Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes","volume":"20","author":"Pyott","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib60","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2174\/1568026033451862","article-title":"Peptidylprolyl cis\/trans isomerases (immunophilins): biological diversity\u2013targets\u2013functions","volume":"3","author":"Galat","year":"2003","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s000180050299","article-title":"Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts","volume":"55","author":"Gothel","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.trsl.2016.11.005_bib62","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1091\/mbc.E02-05-0311","article-title":"A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins","volume":"13","author":"Meunier","year":"2002","journal-title":"Mol Biol Cel"},{"key":"10.1016\/j.trsl.2016.11.005_bib63","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0021-9258(17)35315-2","article-title":"Cyclosporin A slows collagen triple-helix formation in\u00a0vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase","volume":"266","author":"Steinmann","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib64","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1432-1033.1980.tb04610.x","article-title":"Folding mechanism of the triple helix in type-III collagen and type-III pN-collagen. Role of disulfide bridges and peptide bond isomerization","volume":"106","author":"Bachinger","year":"1980","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.trsl.2016.11.005_bib65","doi-asserted-by":"crossref","first-page":"e1004465","DOI":"10.1371\/journal.pgen.1004465","article-title":"Abnormal type I collagen post-translational modification and crosslinking in a cyclophilin B KO mouse model of recessive osteogenesis imperfecta","volume":"10","author":"Cabral","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib66","doi-asserted-by":"crossref","first-page":"9501","DOI":"10.1074\/jbc.M115.699470","article-title":"Cyclophilin-B modulates collagen cross-linking by differentially affecting lysine hydroxylation in the helical and telopeptidyl domains of tendon type I collagen","volume":"291","author":"Terajima","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib67","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.bbamcr.2008.10.005","article-title":"Inositol trisphosphate and calcium signalling mechanisms","volume":"1793","author":"Berridge","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2016.11.005_bib68","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCRESAHA.114.301816","article-title":"Trimeric intracellular cation channels and sarcoplasmic\/endoplasmic reticulum calcium homeostasis","volume":"114","author":"Zhou","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00424-012-1197-5","article-title":"TRIC channels supporting efficient Ca(2+) release from intracellular stores","volume":"465","author":"Venturi","year":"2013","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.trsl.2016.11.005_bib70","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature05928","article-title":"TRIC channels are essential for Ca2+ handling in intracellular stores","volume":"448","author":"Yazawa","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2016.11.005_bib71","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1242\/dev.036798","article-title":"Essential role of the TRIC-B channel in Ca2+ handling of alveolar epithelial cells and in perinatal lung maturation","volume":"136","author":"Yamazaki","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.trsl.2016.11.005_bib72","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jmedgenet-2012-101142","article-title":"Study of autosomal recessive osteogenesis imperfecta in Arabia reveals a novel locus defined by TMEM38B mutation","volume":"49","author":"Shaheen","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib73","first-page":"582","article-title":"A deletion mutation in TMEM38B associated with autosomal recessive osteogenesis imperfecta","volume":"34","author":"Volodarsky","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2016.11.005_bib74","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.gene.2014.05.028","article-title":"A novel deletion mutation involving TMEM38B in a patient with autosomal recessive osteogenesis imperfecta","volume":"545","author":"Rubinato","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.trsl.2016.11.005_bib75","doi-asserted-by":"crossref","first-page":"e1006156","DOI":"10.1371\/journal.pgen.1006156","article-title":"Absence of the ER cation channel TMEM38B\/TRIC-B disrupts intracellular calcium homeostasis and dysregulates collagen synthesis in recessive osteogenesis imperfecta","volume":"12","author":"Cabral","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib76","doi-asserted-by":"crossref","first-page":"ra49","DOI":"10.1126\/scisignal.aad9055","article-title":"Mice lacking the intracellular cation channel TRIC-B have compromised collagen production and impaired bone mineralization","volume":"9","author":"Zhao","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/j.trsl.2016.11.005_bib77","doi-asserted-by":"crossref","first-page":"25399","DOI":"10.1074\/jbc.M102471200","article-title":"HSP47 binds cooperatively to triple helical type I collagen but has little effect on the thermal stability or rate of refolding","volume":"276","author":"Macdonald","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib78","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/(SICI)1096-9896(199802)184:2<212::AID-PATH996>3.0.CO;2-Z","article-title":"The retention of abnormal type I procollagen and correlated expression of HSP 47 in fibroblasts from a patient with lethal osteogenesis imperfecta","volume":"184","author":"Kojima","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.trsl.2016.11.005_bib79","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajhg.2010.01.034","article-title":"Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta","volume":"86","author":"Christiansen","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib80","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1083\/jcb.150.6.1499","article-title":"Embryonic lethality of molecular chaperone hsp47 knockout mice is associated with defects in collagen biosynthesis","volume":"150","author":"Nagai","year":"2000","journal-title":"J Cel Biol"},{"key":"10.1016\/j.trsl.2016.11.005_bib81","doi-asserted-by":"crossref","first-page":"e1000579","DOI":"10.1371\/journal.pgen.1000579","article-title":"A missense mutation in the SERPINH1 gene in Dachshunds with osteogenesis imperfecta","volume":"5","author":"Drogemuller","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib82","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1091\/mbc.E04-01-0050","article-title":"Insufficient folding of type IV collagen and formation of abnormal basement membrane-like structure in embryoid bodies derived from Hsp47-null embryonic stem cells","volume":"15","author":"Matsuoka","year":"2004","journal-title":"Mol Biol Cel"},{"key":"10.1016\/j.trsl.2016.11.005_bib83","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1172\/JCI117617","article-title":"Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis","volume":"94","author":"Masuda","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2016.11.005_bib84","doi-asserted-by":"crossref","first-page":"31584","DOI":"10.1074\/jbc.M802535200","article-title":"The rough endoplasmic reticulum-resident FK506-binding protein FKBP65 is a molecular chaperone that interacts with collagens","volume":"283","author":"Ishikawa","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib85","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1083\/jcb.140.2.295","article-title":"Identification of tropoelastin as a ligand for the 65-kD FK506-binding protein, FKBP65, in the secretory pathway","volume":"140","author":"Davis","year":"1998","journal-title":"J Cel Biol"},{"key":"10.1016\/j.trsl.2016.11.005_bib86","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/bj3300109","article-title":"Chicken FK506-binding protein, FKBP65, a member of the FKBP family of peptidylprolyl cis-trans isomerases, is only partially inhibited by FK506","volume":"330","author":"Zeng","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.trsl.2016.11.005_bib87","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajhg.2010.02.022","article-title":"Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta","volume":"86","author":"Alanay","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib88","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2350-12-152","article-title":"Mutations in FKBP10 can cause a severe form of isolated osteogenesis imperfecta","volume":"12","author":"Steinlein","year":"2011","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib89","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejmg.2011.10.002","article-title":"A novel homozygous 5 bp deletion in FKBP10 causes clinically Bruck syndrome in an Indonesian patient","volume":"55","author":"Setijowati","year":"2012","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib90","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/ajmg.a.34025","article-title":"Mutations in FKBP10 cause both Bruck syndrome and isolated osteogenesis imperfecta in humans","volume":"155A","author":"Shaheen","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2016.11.005_bib91","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajhg.2010.05.020","article-title":"FKBP10 and Bruck syndrome: phenotypic heterogeneity or call for reclassification?","volume":"87","author":"Shaheen","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib92","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jbmr.250","article-title":"Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome","volume":"26","author":"Kelley","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib93","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bone.2011.10.023","article-title":"A novel splicing mutation in FKBP10 causing osteogenesis imperfecta with a possible mineralization defect","volume":"50","author":"Venturi","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.trsl.2016.11.005_bib94","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1093\/hmg\/ddu197","article-title":"Connective tissue alterations in Fkbp10\u2212\/\u2212 mice","volume":"23","author":"Lietman","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib95","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1073\/pnas.1600074113","article-title":"Disentangling mechanisms involved in collagen pyridinoline cross-linking: the immunophilin FKBP65 is critical for dimerization of lysyl hydroxylase 2","volume":"113","author":"Gjaltema","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.11.005_bib96","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1146\/annurev.bi.53.070184.003441","article-title":"Cross-linking in collagen and elastin","volume":"53","author":"Eyre","year":"1984","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.trsl.2016.11.005_bib97","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ajmg.a.30231","article-title":"Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2","volume":"131","author":"Ha-Vinh","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2016.11.005_bib98","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/humu.22362","article-title":"Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations","volume":"34","author":"Barnes","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2016.11.005_bib99","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0003-2697(84)90101-5","article-title":"Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography","volume":"137","author":"Eyre","year":"1984","journal-title":"Anal Biochem"},{"key":"10.1016\/j.trsl.2016.11.005_bib100","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/humu.22133","article-title":"Mutations in PLOD2 cause autosomal-recessive connective tissue disorders within the Bruck syndrome\u2013osteogenesis imperfecta phenotypic spectrum","volume":"33","author":"Puig-Hervas","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2016.11.005_bib101","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","article-title":"Type V osteogenesis imperfecta: a new form of brittle bone disease","volume":"15","author":"Glorieux","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib102","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/ajmg.a.36024","article-title":"Osteogenesis imperfecta type V: clinical and radiographic manifestations in mutation confirmed patients","volume":"161A","author":"Kim","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2016.11.005_bib103","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MCD.0b013e32836032f0","article-title":"Genotype-phenotype study in type V osteogenesis imperfecta","volume":"22","author":"Balasubramanian","year":"2013","journal-title":"Clin Dysmorphol"},{"key":"10.1016\/j.trsl.2016.11.005_bib104","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s13312-016-0830-3","article-title":"Worsening of callus hyperplasia after bisphosphonate treatment in type V osteogenesis imperfecta","volume":"53","author":"Ranganath","year":"2016","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.trsl.2016.11.005_bib105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/jmedgenet-2012-101307","article-title":"Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.\u221214C>T mutation in all patients","volume":"50","author":"Rauch","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib106","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/jbmr.1891","article-title":"Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation","volume":"28","author":"Shapiro","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib107","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajhg.2012.06.005","article-title":"A single recurrent mutation in the 5\u02b9-UTR of IFITM5 causes osteogenesis imperfecta type V","volume":"91","author":"Cho","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib108","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajhg.2012.06.011","article-title":"A mutation in the 5\u02b9-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus","volume":"91","author":"Semler","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib109","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/ajmg.a.36025","article-title":"A recurrent mutation in the 5\u02b9-UTR of IFITM5 causes osteogenesis imperfecta type V","volume":"161A","author":"Takagi","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2016.11.005_bib110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2474-15-107","article-title":"The IFITM5 mutation c.\u221214C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V","volume":"15","author":"Lazarus","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.trsl.2016.11.005_bib111","doi-asserted-by":"crossref","first-page":"E325","DOI":"10.1210\/jc.2014-3082","article-title":"Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression","volume":"100","author":"Reich","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2016.11.005_bib112","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jbmr.2363","article-title":"A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation","volume":"30","author":"Lietman","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib113","series-title":"Crispr-Cas9 engineered mouse model for osteogenesis imperfecta Type V","author":"Moffatt","year":"2016"},{"key":"10.1016\/j.trsl.2016.11.005_bib114","doi-asserted-by":"crossref","first-page":"13278","DOI":"10.1074\/jbc.M113.457010","article-title":"Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation","volume":"288","author":"Kasaai","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib115","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/jbmr.2173","article-title":"A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor","volume":"29","author":"Farber","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib116","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ajmg.a.36409","article-title":"Two mutations in IFITM5 causing distinct forms of osteogenesis imperfecta","volume":"164A","author":"Guillen-Navarro","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2016.11.005_bib117","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/jbmr.2156","article-title":"A nonclassical IFITM5 mutation located in the coding region causes severe osteogenesis imperfecta with prenatal onset","volume":"29","author":"Hoyer-Kuhn","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib118","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1359\/jbmr.080412","article-title":"Bril: a novel bone-specific modulator of mineralization","volume":"23","author":"Moffatt","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib119","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1432-1033.1991.tb16139.x","article-title":"Molecular analysis of a human interferon-inducible gene family","volume":"199","author":"Lewin","year":"1991","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.trsl.2016.11.005_bib120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jbm.a.31240","article-title":"Phenotype and gene expression pattern of osteoblast-like cells cultured on polystyrene and hydroxyapatite with pre-adsorbed type-I collagen","volume":"83","author":"Hanagata","year":"2007","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.trsl.2016.11.005_bib121","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00774-010-0221-0","article-title":"Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice","volume":"29","author":"Hanagata","year":"2011","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.trsl.2016.11.005_bib122","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/jbmr.2243","article-title":"Topological mapping of BRIL reveals a type II orientation and effects of osteogenesis imperfecta mutations on its cellular destination","volume":"29","author":"Patoine","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib123","doi-asserted-by":"crossref","first-page":"e75831","DOI":"10.1371\/journal.pone.0075831","article-title":"Role of S-palmitoylation on IFITM5 for the interaction with FKBP11 in osteoblast cells","volume":"8","author":"Tsukamoto","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.11.005_bib124","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2011.04.136","article-title":"Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferon-induced genes","volume":"409","author":"Hanagata","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2016.11.005_bib125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajhg.2011.01.015","article-title":"Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta","volume":"88","author":"Becker","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib126","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/jbmr.487","article-title":"Mutations in SERPINF1 cause osteogenesis imperfecta type VI","volume":"26","author":"Homan","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib127","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jbmr.1480","article-title":"Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen","volume":"27","author":"Venturi","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib128","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3346\/jkms.2013.28.7.1107","article-title":"Osteogenesis imperfecta Type VI with severe bony deformities caused by novel compound heterozygous mutations in SERPINF1","volume":"28","author":"Cho","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.trsl.2016.11.005_bib129","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000369108","article-title":"Novel deletion of SERPINF1 causes autosomal recessive osteogenesis imperfecta type VI in two Brazilian families","volume":"5","author":"Minillo","year":"2014","journal-title":"Mol Syndromol"},{"key":"10.1016\/j.trsl.2016.11.005_bib130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1517\/17460441.2013.794781","article-title":"The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?","volume":"8","author":"Crawford","year":"2013","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.trsl.2016.11.005_bib131","doi-asserted-by":"crossref","first-page":"E1550","DOI":"10.1210\/jc.2012-1827","article-title":"Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI","volume":"97","author":"Rauch","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2016.11.005_bib132","doi-asserted-by":"crossref","first-page":"E2446","DOI":"10.1210\/jc.2014-2505","article-title":"Normal bone density and fat mass in heterozygous SERPINF1 mutation carriers","volume":"99","author":"Al-Jallad","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2016.11.005_bib133","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1359\/jbmr.2002.17.1.30","article-title":"Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect","volume":"17","author":"Glorieux","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib134","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.1892","article-title":"A mouse model for human osteogenesis imperfecta type VI","volume":"28","author":"Bogan","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bone.2014.12.023","article-title":"Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone","volume":"73","author":"Fratzl-Zelman","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.trsl.2016.11.005_bib136","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/jcp.24859","article-title":"Pigment epithelium derived factor suppresses expression of SOST\/sclerostin by osteocytes: implication for its role in bone matrix mineralization","volume":"230","author":"Li","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.trsl.2016.11.005_bib137","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/ajmg.a.35319","article-title":"A co-occurrence of osteogenesis imperfecta type VI and cystinosis","volume":"158A","author":"Tucker","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2016.11.005_bib138","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejmg.2014.10.001","article-title":"Mutations in patients with osteogenesis imperfecta from consanguineous Indian families","volume":"58","author":"Stephen","year":"2015","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib139","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2015.04.008","article-title":"The effect of SERPINF1 in-frame mutations in osteogenesis imperfecta type VI","volume":"76","author":"Al-Jallad","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.trsl.2016.11.005_bib140","doi-asserted-by":"crossref","first-page":"26364","DOI":"10.1074\/jbc.M111.252684","article-title":"Pigment epithelium-derived factor (PEDF) shares binding sites in collagen with heparin\/heparan sulfate proteoglycans","volume":"286","author":"Sekiya","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib141","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1021\/bi0206558","article-title":"Dual-site recognition of different extracellular matrix components by anti-angiogenic\/neurotrophic serpin, PEDF","volume":"42","author":"Yasui","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.trsl.2016.11.005_bib142","first-page":"183","article-title":"First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI","volume":"12","author":"Semler","year":"2012","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.trsl.2016.11.005_bib143","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00223-016-0110-1","article-title":"Osteogenesis imperfecta type VI in individuals from Northern Canada","volume":"98","author":"Ward","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.trsl.2016.11.005_bib144","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbrc.2009.11.139","article-title":"PEDF regulates osteoclasts via osteoprotegerin and RANKL","volume":"391","author":"Akiyama","year":"2010","journal-title":"Biochem biophysical Res Commun"},{"key":"10.1016\/j.trsl.2016.11.005_bib145","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ymgme.2015.11.015","article-title":"Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice","volume":"117","author":"Rajagopal","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2016.11.005_bib146","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1096\/fj.201500027R","article-title":"Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade","volume":"30","author":"Belinsky","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2016.11.005_bib147","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bbrc.2005.07.140","article-title":"Involvement of the collagen I-binding motif in the anti-angiogenic activity of pigment epithelium-derived factor","volume":"335","author":"Hosomichi","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2016.11.005_bib148","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1128\/MCB.01211-10","article-title":"Identification of a novel inhibitor of the canonical Wnt pathway","volume":"31","author":"Park","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.trsl.2016.11.005_bib149","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jcmgh.2015.06.006","article-title":"Pigment epithelium-derived factor (PEDF) inhibits Wnt\/-catenin signaling in the liver","volume":"1","author":"Protiva","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2016.11.005_bib150","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/stem.1505","article-title":"Pigment epithelium-derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells","volume":"31","author":"Li","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.trsl.2016.11.005_bib151","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1096\/fj.13-232900","article-title":"Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content","volume":"27","author":"Gattu","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2016.11.005_bib152","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/ijms17050730","article-title":"Pigment epithelium-derived factor (PEDF) protects osteoblastic cell line from glucocorticoid-induced apoptosis via PEDF-R","volume":"17","author":"Yao","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2016.11.005_bib153","doi-asserted-by":"crossref","first-page":"e05401","DOI":"10.7554\/eLife.05401","article-title":"Identification of PLXDC1 and PLXDC2 as the transmembrane receptors for the multifunctional factor PEDF","volume":"3","author":"Cheng","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.trsl.2016.11.005_bib154","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajhg.2010.05.016","article-title":"Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta","volume":"87","author":"Lapunzina","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.gene.2004.05.026","article-title":"Molecular cloning, structure, expression, and chromosomal localization of the human Osterix (SP7) gene","volume":"341","author":"Gao","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.trsl.2016.11.005_bib156","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","article-title":"The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation","volume":"108","author":"Nakashima","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2016.11.005_bib157","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jcp.21176","article-title":"Osterix\/Sp7 regulates mesenchymal stem cell mediated endochondral ossification","volume":"214","author":"Kaback","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.trsl.2016.11.005_bib158","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.bbrc.2016.01.112","article-title":"TIEG1 enhances Osterix expression and mediates its induction by TGFbeta and BMP2 in osteoblasts","volume":"470","author":"Subramaniam","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2016.11.005_bib159","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bone.2012.11.007","article-title":"Osterix induces Col1a1 gene expression through binding to Sp1 sites in the bone enhancer and proximal promoter regions","volume":"52","author":"Ortuno","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.trsl.2016.11.005_bib160","doi-asserted-by":"crossref","first-page":"e52948","DOI":"10.1371\/journal.pone.0052948","article-title":"Synergistic inhibition of Wnt pathway by HIF-1alpha and osteoblast-specific transcription factor osterix (Osx) in osteoblasts","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.11.005_bib161","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7150\/ijbs.10874","article-title":"Osterix controls cementoblast differentiation through downregulation of Wnt-signaling via enhancing DKK1 expression","volume":"11","author":"Cao","year":"2015","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.trsl.2016.11.005_bib162","first-page":"659","article-title":"Molecular mechanisms of osteoblast-specific transcription factor osterix effect on bone formation","volume":"44","author":"Zhang","year":"2012","journal-title":"Beijing Da Xue Xue Bao"},{"key":"10.1016\/j.trsl.2016.11.005_bib163","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00223-016-0144-4","article-title":"Osterix and RUNX2 are transcriptional regulators of sclerostin in human bone","volume":"99","author":"Perez-Campo","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.trsl.2016.11.005_bib164","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/embor.2011.34","article-title":"The IRE1alpha-XBP1 pathway is essential for osteoblast differentiation through promoting transcription of Osterix","volume":"12","author":"Tohmonda","year":"2011","journal-title":"EMBO Rep"},{"key":"10.1016\/j.trsl.2016.11.005_bib165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jmedgenet-2013-101567","article-title":"Mutations in WNT1 are a cause of osteogenesis imperfecta","volume":"50","author":"Fahiminiya","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib166","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ajhg.2013.02.010","article-title":"Mutations in WNT1 cause different forms of bone fragility","volume":"92","author":"Keupp","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib167","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ajhg.2013.02.009","article-title":"WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta","volume":"92","author":"Pyott","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib168","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1215458","article-title":"WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta","volume":"368","author":"Laine","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.11.005_bib169","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/jbmr.2841","article-title":"Skeletal characteristics of WNT1 osteoporosis in children and young adults","volume":"31","author":"Makitie","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib170","first-page":"2392","article-title":"Mutations and altered expression of SERPINF1 in patients with familial otosclerosis","volume":"25","author":"Ziff","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib171","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cellsig.2011.01.007","article-title":"Fatty acid modification of Wnt1 and Wnt3a at serine is prerequisite for lipidation at cysteine and is essential for Wnt signalling","volume":"23","author":"Doubravska","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.trsl.2016.11.005_bib172","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1016\/j.febslet.2014.11.016","article-title":"Identification of the WNT1 residues required for palmitoylation by Porcupine","volume":"588","author":"Miranda","year":"2014","journal-title":"FEBS Lett"},{"key":"10.1016\/j.trsl.2016.11.005_bib173","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2016.11.005_bib174","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0092-8674(90)90385-R","article-title":"The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain","volume":"62","author":"McMahon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2016.11.005_bib175","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0092-8674(91)90369-A","article-title":"Swaying is a mutant allele of the proto-oncogene Wnt-1","volume":"67","author":"Thomas","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2016.11.005_bib176","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/jmedgenet-2013-101750","article-title":"WNT1 mutation with recessive osteogenesis imperfecta and profound neurological phenotype","volume":"50","author":"Faqeih","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib177","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jbmr.2586","article-title":"Osteoclast TGF-beta receptor signaling induces Wnt1 secretion and couples bone resorption to bone formation","volume":"31","author":"Weivoda","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib178","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ajhg.2015.04.021","article-title":"Recessive osteogenesis imperfecta caused by missense mutations in SPARC","volume":"96","author":"Mendoza-Londono","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib179","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.matbio.2016.02.001","article-title":"SPARC\/osteonectin in mineralized tissue","volume":"52-54","author":"Rosset","year":"2016","journal-title":"Matrix Biol"},{"key":"10.1016\/j.trsl.2016.11.005_bib180","doi-asserted-by":"crossref","first-page":"18273","DOI":"10.1073\/pnas.0808452105","article-title":"Structural basis of sequence-specific collagen recognition by SPARC","volume":"105","author":"Hohenester","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.11.005_bib181","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/emboj\/17.6.1625","article-title":"Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40\/SPARC\/osteonectin","volume":"17","author":"Sasaki","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.trsl.2016.11.005_bib182","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/154405910708600402","article-title":"Is SPARC an evolutionarily conserved collagen chaperone?","volume":"86","author":"Martinek","year":"2007","journal-title":"J Dent Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib183","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/jbmr.2522","article-title":"Decreased mechanical strength and collagen content in SPARC-null periodontal ligament is reversed by inhibition of transglutaminase activity","volume":"30","author":"Trombetta-eSilva","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib184","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1172\/JCI7039","article-title":"Osteopenia and decreased bone formation in osteonectin-deficient mice","volume":"105","author":"Delany","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2016.11.005_bib185","doi-asserted-by":"crossref","first-page":"11920","DOI":"10.1038\/ncomms11920","article-title":"MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta","volume":"7","author":"Lindert","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2016.11.005_bib186","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1308223","article-title":"PLS3 mutations in X-linked osteoporosis with fractures","volume":"369","author":"van Dijk","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2016.11.005_bib187","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/jbmr.2208","article-title":"Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics","volume":"29","author":"Fahiminiya","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trsl.2016.11.005_bib188","doi-asserted-by":"crossref","first-page":"21973","DOI":"10.1074\/jbc.274.31.21973","article-title":"Membrane topology of S2P, a protein required for intramembranous cleavage of sterol regulatory element-binding proteins","volume":"274","author":"Zelenski","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2016.11.005_bib189","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0092-8674(00)80675-3","article-title":"Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans","volume":"100","author":"Brown","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2016.11.005_bib190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1042\/bse0380155","article-title":"Regulated intramembrane proteolysis: from the endoplasmic reticulum to the nucleus","volume":"38","author":"Rawson","year":"2002","journal-title":"Essays Biochem"},{"key":"10.1016\/j.trsl.2016.11.005_bib191","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ajhg.2009.03.014","article-title":"IFAP syndrome is caused by deficiency in MBTPS2, an intramembrane zinc metalloprotease essential for cholesterol homeostasis and ER stress response","volume":"84","author":"Oeffner","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2016.11.005_bib192","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajmg.a.34373","article-title":"MBTPS2 mutation causes BRESEK\/BRESHECK syndrome","volume":"158A","author":"Naiki","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.trsl.2016.11.005_bib193","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/humu.21335","article-title":"Keratosis follicularis spinulosa decalvans is caused by mutations in MBTPS2","volume":"31","author":"Aten","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2016.11.005_bib194","first-page":"587","article-title":"Genotype-phenotype correlations emerging from the identification of missense mutations in MBTPS2","volume":"34","author":"Bornholdt","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2016.11.005_bib195","doi-asserted-by":"crossref","first-page":"14765","DOI":"10.1073\/pnas.96.26.14765","article-title":"A family of membrane-embedded metalloproteases involved in regulated proteolysis of membrane-associated transcription factors","volume":"96","author":"Rudner","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.11.005_bib196","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/sqb.2002.67.491","article-title":"SREBPs: transcriptional mediators of lipid homeostasis","volume":"67","author":"Horton","year":"2002","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.trsl.2016.11.005_bib197","doi-asserted-by":"crossref","first-page":"14024","DOI":"10.1073\/pnas.2331794100","article-title":"Site-1 protease is required for cartilage development in zebrafish","volume":"100","author":"Schlombs","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.11.005_bib198","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1083\/jcb.200708092","article-title":"Site-1 protease is essential for endochondral bone formation in mice","volume":"179","author":"Patra","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.trsl.2016.11.005_bib199","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1750-1172-8-154","article-title":"Deficiency for the ER-stress transducer OASIS causes severe recessive osteogenesis imperfecta in humans","volume":"8","author":"Symoens","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.trsl.2016.11.005_bib200","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0006-291X(02)00253-X","article-title":"OASIS is a transcriptional activator of CREB\/ATF family with a transmembrane domain","volume":"293","author":"Omori","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2016.11.005_bib201","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ncb1213","article-title":"OASIS, a CREB\/ATF-family member, modulates UPR signalling in astrocytes","volume":"7","author":"Kondo","year":"2005","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.trsl.2016.11.005_bib202","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1471-4159.2005.03596.x","article-title":"Cleavage of the membrane-bound transcription factor OASIS in response to endoplasmic reticulum stress","volume":"96","author":"Murakami","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.trsl.2016.11.005_bib203","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1038\/cdd.2012.77","article-title":"Activation of OASIS family, ER stress transducers, is dependent on its stabilization","volume":"19","author":"Kondo","year":"2012","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.trsl.2016.11.005_bib204","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bone.2010.10.176","article-title":"Distinct mechanisms are responsible for osteopenia and growth retardation in OASIS-deficient mice","volume":"48","author":"Murakami","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.trsl.2016.11.005_bib205","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ncb1963","article-title":"Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation","volume":"11","author":"Murakami","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.trsl.2016.11.005_bib206","doi-asserted-by":"crossref","first-page":"16455","DOI":"10.1038\/srep16455","article-title":"OASIS modulates hypoxia pathway activity to regulate bone angiogenesis","volume":"5","author":"Cui","year":"2015","journal-title":"Sci Rep"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416303723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416303723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T05:10:13Z","timestamp":1657775413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524416303723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":206,"alternative-id":["S1931524416303723"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2016.11.005","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteogenesis imperfecta: new genes reveal novel mechanisms in bone dysplasia","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2016.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}